(Q54331857)

1 July 2019

title

Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells. (English)

1 reference

1 July 2019

author name string

R S Watnick

1

1 reference

1 July 2019

R K Rodriguez

2

1 reference

1 July 2019

S Wang

3

1 reference

1 July 2019

A L Blois

4

1 reference

1 July 2019

A Rangarajan

5

1 reference

1 July 2019

T Ince

6

1 reference

1 July 2019

R A Weinberg

7

1 reference

1 July 2019

language of work or name

English

0 references

publication date

11 August 2014

1 reference

1 July 2019

published in

Oncogene

1 reference

1 July 2019

volume

34

1 reference

1 July 2019

issue

22

1 reference

1 July 2019

page(s)

2823-2835

1 reference

1 July 2019

https://scigraph.springernature.com/pub.10.1038/onc.2014.228

exact match

0 references

cites work

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Extension of life-span by introduction of telomerase into normal human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Basic fibroblast growth factor fused to a signal peptide transforms cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

CD47 functions as a molecular switch for erythrocyte phagocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Miz1 is required for early embryonic development during gastrulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The significance of oncogene amplification in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Multiple Ras functions can contribute to mammalian cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The pims and outs of survival signaling: role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Signal transduction in T lymphocytes using a conditional allele of Sos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The small GTP-binding protein rac regulates growth factor-induced membrane ruffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Transformation mediated by RhoA requires activity of ROCK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Creation of human tumour cells with defined genetic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Role of T antigen interactions with p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The role of the SV40 ST antigen in cell growth promotion and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Isolation and propagation of a segment of the simian virus 40 genome containing the origin of DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The E2F transcription factor is a cellular target for the RB protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Essential role for oncogenic Ras in tumour maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

PTEN controls tumor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Genomic analysis of metastasis reveals an essential role for RhoC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Determination of GTP loading on Rho

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

A transcriptional cross-talk between RhoA and c-Myc inhibits the RhoA/Rock-dependent cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Amplification and expression of the c-myc oncogene in human lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Angiostatin induces and sustains dormancy of human primary tumors in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1a with Ras

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

DNA binding and sedimentation properties of SV40 T antigens synthesized in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Assessing sequential oncogene amplification in human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.228

Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells

31 March 2020

1 reference

12 December 2020

Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line

1 reference

12 December 2020

Switch to the angiogenic phenotype during tumorigenesis

1 reference

12 December 2020

Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts

1 reference

12 December 2020

Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast

1 reference

12 December 2020

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)

1 reference

12 December 2020

Construction and analysis of viable deletion mutants of simian virus 40

1 reference

12 December 2020

A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression

1 reference

12 December 2020

Tumor angiogenesis and metastasis: correlation in invasive renal cell carcinoma

1 reference

12 December 2020

Amplification, Expression and Rearrangement of c-myc and N-myc Oncogenes in Human Lung Cancer

1 reference

12 December 2020

Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells

1 reference

12 December 2020

PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death

1 reference

12 December 2020

Copy number of cancer genes predict tumor grade and survival of pancreatic cancer patients

1 reference

12 December 2020

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

1 reference

12 December 2020

Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells

1 reference

12 December 2020

Measurement of oxygen diffusion distance in tumor cubes using a fluorescent hypoxia probe

1 reference

12 December 2020

A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line

1 reference

12 December 2020

Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells

1 reference

12 December 2020

An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.

1 reference

12 December 2020

Nucleotide sequence deletions within the coding region for small-t antigen of simian virus 40

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2014.228

1 reference

1 July 2019

PMC publication ID

6293990

1 reference

1 July 2019

PubMed publication ID

25109329

1 reference

1 July 2019